2-甲基-1,3-苯并二氧戊环 | 14046-39-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 中文名称: 2-甲基-1,3-苯并二氧戊环
• 英文名称: 2-Methyl-1,3-benzodioxole
• 英文别名: 2-methyl benzodioxole；2-methyl-benzo[1,3]dioxole；2-Methyl-benzo[1,3]dioxol；methylbenzo[1.3]dioxole
• CAS: 14046-39-0
• 化学式: C₈H₈O₂
• 分子量: 136.15
• InChiKey: AYEXQFUNWFFKAP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-甲基-1,3-苯并二氧戊环 在 硝酸 作用下， 以 溶剂黄146 为溶剂， 生成 2-methyl-5-nitro-benzo[1,3]dioxole
  参考文献：
  名称：

  Imidazole derivatives

  摘要：

  Tricyclic imidazole derivatives of the formula ##STR1## wherein R.sup.1 is 2-pyridyl optionally substituted by lower alkyl or lower alkoxy, n is the integer 0 or 1, R.sup.2 is hydrogen or lower alkyl, R.sup.3 and R.sup.4, independently, are hydrogen or lower alkyl, A is a group of the formula ##STR2## m is the integer 2 or 3, R.sup.5, R.sup.6, R.sup.7 and R.sup.8, independently, are hydrogen or lower alkyl, and R.sup.9 is hydrogen and R.sup.10 is hydrogen or lower alkyl or R.sup.9 and R.sup.10 taken together are oxo, provided that at least one of R.sup.3 and R.sup.4 is lower alkyl when A is a group of the formula --CH.dbd.CH--CH.dbd.CH-- or --(CH.sub.2).sub.4 --, and their pharmaceutically acceptable acid addition salts. The compounds of formula I inhibit gastric acid secretion and prevent the formation of gastric ulcers.

  公开号：

  US04435406A1
• 作为产物：
  描述：

  邻苯二酚 、 三聚乙醛 在 对甲苯磺酸 作用下， 以 苯 为溶剂， 生成 2-甲基-1,3-苯并二氧戊环
  参考文献：
  名称：

  Antioxidant benzodioxole compound

  摘要：

  描述了用于含有油或脂肪的食品中的新型抗氧化剂化合物，其包括具有结构##STR1##的苯二氧杂环己烷化合物，其中R.sub.1是氢原子或烷基或芳基，R.sub.2是烷基或芳基，或R.sub.1和R.sub.2共同形成环烷基，R.sub.3是氢原子或羟基。

  公开号：

  US04499115A1

文献信息

• [EN] HIV PROTEASE INHIBITING COMPOUNDS<br/>[FR] COMPOSES INHIBITEURS DE LA PROTEASE DU VIH
  申请人：ABBOTT LAB

  公开号：WO2005061487A1

  公开（公告）日：2005-07-07

  A compound of the formula (I) is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

  公开了一种公式(I)的化合物作为HIV蛋白酶抑制剂。还公开了用于抑制HIV感染的方法和组合物。
• NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE
  申请人：Okano Akihiro

  公开号：US20120157459A1

  公开（公告）日：2012-06-21

  [Problem] To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogue and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of solving the problem] A compound of Formula (I): (where n is 0 to 2; p is 0 to 4; j is 0 to 3; k is 0 to 2; a ring A is an aryl group which is optionally substituted with L or a heterocyclic group which is optionally substituted with L; a ring B is a benzene ring, a pyridine ring, or a pyrimidine ring; X is O, S, —NR 7 —; and R 1 to R 7 are specific groups), a salt of the compound, or a solvate of the salt or the compound.

  提供一个以新型化合物作为活性成分的GPR40激活剂，该化合物具有GPR40激动剂作用，该化合物的盐，该盐或化合物的溶剂合物，或者类似物，尤其是胰岛素分泌促进剂以及对糖尿病、肥胖症或其他疾病的预防及/或治疗剂。[解决该问题的方法] 公式(I)的化合物：（其中n为0至2；p为0至4；j为0至3；k为0至2；环A是一个芳基团，可选择性被L取代或是一个杂环团，可选择性被L取代；环B是一个苯环、一个吡啶环或一个嘧啶环；X是O，S，—NR7—；R1至R7是特定基团），该化合物的盐，或该盐或化合物的溶剂合物。
• Formation and reactivity of 1,3-benzodioxol-2-yl, 1,3-benzodioxan-2-yl, and related radicals. A search for an aromatic analog of the radical acetoxy rearrangement (Surzur–Tanner reaction)
  作者：Fereidoon Shahidi、Thomas T. Tidwell

  DOI：10.1139/v82-162

  日期：1982.5.1

  Reaction of the 1,3-dioxole, 9, the 1,3-dioxan, 18, and the 1,3-dioxepin, 29, with tert-butoxy radicals gave evidence in each case for formation of the corresponding 1,1-dioxyethyl radicals. No conclusive evidence for formation of any of these radicals by cyclization of acetoxyaryl radicals could be obtained. Several of the 1,1-dioxyethyl radicals reacted by rearrangement.

  1,3-二氧杂环戊烷（9）、1,3-二氧杂环己烷（18）和1,3-二氧杂环庚烷（29）与叔丁氧基自由基反应，在每种情况下都证明了相应1,1-二氧乙基自由基的形成。没有获得任何这些自由基是通过乙酰氧基芳基自由基环化形成的结论性证据。其中几种1,1-二氧乙基自由基通过重排反应。

• PHARMACEUTICAL COMPOUNDS
  申请人：Kiss Laszlo Erno

  公开号：US20120065191A1

  公开（公告）日：2012-03-15

  The invention relates to compounds and compositions for inhibiting the enzyme fatty acid amide hydrolase (FAAH), the use of the compounds in therapy and, in particular, for treating or preventing conditions whose development or symptoms are linked to substrates of the FAAH enzyme, and methods of treatment or prevention using the compounds and compositions.

  这项发明涉及抑制脂肪酰胺水解酶（FAAH）的化合物和组合物，以及在治疗中使用这些化合物，特别是用于治疗或预防与FAAH酶底物相关的疾病的发展或症状的条件，以及使用这些化合物和组合物进行治疗或预防的方法。
• Substituted piperidines and methods of use
  申请人：——

  公开号：US20040006067A1

  公开（公告）日：2004-01-08

  Selected substituted piperidine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的替代哌啶化合物对预防和治疗疾病，如肥胖等，具有有效性。该发明涵盖了新颖化合物、类似物、前药和其药用可接受盐，以及用于预防和治疗涉及黑素皮质素受体激活的疾病和其他疾病或病症的药物组合物和方法。该发明还涉及制备此类化合物的方法，以及在此类方法中有用的中间体。